495 related articles for article (PubMed ID: 15051927)
1. SAG1 is a host-targeted antigen for protection against toxoplasma gondii infection.
Seng S; Makala LH; Yokoyama M; Lim C; Choi YH; Suzuki N; Toyoda Y; Nagasawa H
Pathobiology; 2004; 71(3):144-51. PubMed ID: 15051927
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.
Qu D; Wang S; Cai W; Du A
Vaccine; 2008 Aug; 26(35):4541-8. PubMed ID: 18590785
[TBL] [Abstract][Full Text] [Related]
3. Unresponsiveness to surface antigen 1 modifies cytokine profiles in acute Toxoplasma gondii infection.
Seng S; Makala LH; Maki Y; Choi Y; Yokoyama M; Suzuki N; Toyoda Y; Nagasawa H
Pathobiology; 2002-2003; 70(4):237-46. PubMed ID: 12679602
[TBL] [Abstract][Full Text] [Related]
4. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model.
Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J
Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii.
Fang R; Feng H; Hu M; Khan MK; Wang L; Zhou Y; Zhao J
Vet Parasitol; 2012 Jun; 187(1-2):140-6. PubMed ID: 22336771
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis.
Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H
Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690
[TBL] [Abstract][Full Text] [Related]
7. Oral immunization with a live recombinant attenuated Salmonella typhimurium protects mice against Toxoplasma gondii.
Cong H; Gu QM; Jiang Y; He SY; Zhou HY; Yang TT; Li Y; Zhao QL
Parasite Immunol; 2005; 27(1-2):29-35. PubMed ID: 15813720
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity and protective efficacy of two recombinant pseudorabies viruses expressing Toxoplasma gondii SAG1 and MIC3 proteins.
Nie H; Fang R; Xiong BQ; Wang LX; Hu M; Zhou YQ; Zhao JL
Vet Parasitol; 2011 Sep; 181(2-4):215-21. PubMed ID: 21632181
[TBL] [Abstract][Full Text] [Related]
9. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice.
Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H
Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice.
Mévélec MN; Bout D; Desolme B; Marchand H; Magné R; Bruneel O; Buzoni-Gatel D
Vaccine; 2005 Aug; 23(36):4489-99. PubMed ID: 15935521
[TBL] [Abstract][Full Text] [Related]
11. [Immune response elicited by the recombinant protein and plasmid DNA of complex antigen ROP2-SAG1 from Toxoplasma gondii].
Li WS; Xie ZX; Chen QX; Chen S; Zhang LF
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2010 Oct; 28(5):359-63. PubMed ID: 21351549
[TBL] [Abstract][Full Text] [Related]
12. Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice.
Wang H; He S; Yao Y; Cong H; Zhao H; Li T; Zhu XQ
Exp Parasitol; 2009 Jul; 122(3):226-32. PubMed ID: 19366622
[TBL] [Abstract][Full Text] [Related]
13. Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes.
Li B; Oledzka G; McFarlane RG; Spellerberg MB; Smith SM; Gelder FB; Kur J; Stankiewicz M
Parasite Immunol; 2010; 32(9-10):671-83. PubMed ID: 20691019
[TBL] [Abstract][Full Text] [Related]
14. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice.
Chen J; Huang SY; Li ZY; Yuan ZG; Zhou DH; Petersen E; Zhang NZ; Zhu XQ
Vaccine; 2013 Mar; 31(13):1734-9. PubMed ID: 23370151
[TBL] [Abstract][Full Text] [Related]
15. Reactivity of synthetic SAG1 (p30) peptide sequences with RH, S273 and Beverley strain-induced anti-Toxoplasma gondii antibodies.
Kato M; Claveria FG; Maki Y; Sanda K; Tanaka T; Omata Y; Nagasawa H; Suzuki N
Pathobiology; 2007; 74(1):50-6. PubMed ID: 17496433
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of DNA-mediated immunization with a combination of SAG1 and IL-2 gene adjuvant against infection of Toxoplasma gondii in mice.
Chen G; Chen H; Guo H; Zheng H
Chin Med J (Engl); 2002 Oct; 115(10):1448-52. PubMed ID: 12490084
[TBL] [Abstract][Full Text] [Related]
17. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection.
Zhang M; Zhao L; Song J; Li Y; Zhao Q; He S; Cong H
Vaccine; 2013 Sep; 31(41):4536-40. PubMed ID: 23933373
[TBL] [Abstract][Full Text] [Related]
18. Vaccination against murine toxoplasmosis using recombinant Toxoplasma gondii SAG3 antigen alone or in combination with Quil A.
Lee YH; Shin DW; Lee JH; Nam HW; Ahn MH
Yonsei Med J; 2007 Jun; 48(3):396-404. PubMed ID: 17594146
[TBL] [Abstract][Full Text] [Related]
19. [Immune response in mice induced by complex gene vaccine pcSAG1-ROP5 of Toxoplasma gondii].
Zhao HG; Fan ZG; Huang FY; Huang YH; Zhou SL; Lin YY; Tan GH
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Feb; 31(1):1-5. PubMed ID: 24812827
[TBL] [Abstract][Full Text] [Related]
20. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice.
Zheng B; Lu S; Tong Q; Kong Q; Lou D
Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]